Evidence map›Paper›PMID 26835661›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Modified Nucleotides for Discrimination between Cytosine and the Epigenetic Marker 5-Methylcytosine.

Janina von Watzdorf, Kim Leitner, Andreas Marx

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Snapshots of a modified nucleotide moving through the confines of a DNA polymerase.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Janina von WatzdorfFachbereich Chemie, Graduiertenschule Chemische, Biologie Konstanz, Universität Konstanz, Universitätsstrasse 10, 78457, Konstanz, Deutschland.
Kim LeitnerFachbereich Chemie, Graduiertenschule Chemische, Biologie Konstanz, Universität Konstanz, Universitätsstrasse 10, 78457, Konstanz, Deutschland.
Andreas MarxFachbereich Chemie, Graduiertenschule Chemische, Biologie Konstanz, Universität Konstanz, Universitätsstrasse 10, 78457, Konstanz, Deutschland. andreas.marx@uni-konstanz.de.
University of Konstanz · DE

Funding

European Research Council 339834
6 · The paper itself

Abstract

5-Methyl-2'-deoxycytosine, the most common epigenetic marker of DNA in eukaryotic cells, plays a key role in gene regulation and affects various cellular processes such as development and carcinogenesis. Therefore, the detection of 5mC can serve as an important biomarker for diagnostics. Here we describe that modified dGTP analogues as well as modified primers are able to sense the presence or absence of a single methylation of C, even though this modification does not interfere directly with Watson-Crick nucleobase pairing. By screening several modified nucleotide scaffolds, O(6)-modified 2'-deoxyguanosine analogues were identified as discriminating between C and 5mC. These modified nucleotides might find application in site-specific 5mC detection, for example, through real-time PCR approaches.

Indexed as

Epigenesis, GeneticGenetic Markers5-MethylcytosineCytosineNucleotidesReal-Time Polymerase Chain Reaction5-MethylcytosineCytosineGenetic MarkersNucleotides5-methylcytosineDNA methylationDNA polymeraseepigeneticspolymerase chain reaction

Identifiers

PMID26835661
PMCPMC4949677
OpenAlexW2334213118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.